These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys. Macdonald RL; Weir BK; Young JD; Grace MG J Neurosurg; 1992 Jan; 76(1):81-90. PubMed ID: 1727173 [TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. Kolias AG; Sen J; Belli A J Neurosci Res; 2009 Jan; 87(1):1-11. PubMed ID: 18709660 [TBL] [Abstract][Full Text] [Related]
25. Hyperacute Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Bar B; MacKenzie L; Hurst RW; Grant R; Weigele J; Bhalla PK; Kumar MA; Stiefel MF; Levine JM Neurocrit Care; 2016 Apr; 24(2):180-8. PubMed ID: 26198438 [TBL] [Abstract][Full Text] [Related]
26. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome. Faust K; Horn P; Schneider UC; Vajkoczy P Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804 [TBL] [Abstract][Full Text] [Related]
27. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Springborg JB; Ma X; Rochat P; Knudsen GM; Amtorp O; Paulson OB; Juhler M; Olsen NV Br J Pharmacol; 2002 Feb; 135(3):823-9. PubMed ID: 11834631 [TBL] [Abstract][Full Text] [Related]
28. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [TBL] [Abstract][Full Text] [Related]
29. Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist. Dupont SA; Wijdicks EF; Lanzino G; Rabinstein AA Semin Neurol; 2010 Nov; 30(5):545-54. PubMed ID: 21207347 [TBL] [Abstract][Full Text] [Related]
30. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. Findlay JM Can J Neurol Sci; 1997 May; 24(2):161-70. PubMed ID: 9164696 [TBL] [Abstract][Full Text] [Related]
31. The Utility of Ankle-Brachial Index as a Predictor of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. Guan J; Karsy M; Brock A; Couldwell WT World Neurosurg; 2016 May; 89():139-46. PubMed ID: 26828462 [TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage: A Review of the Literature. Inagawa T World Neurosurg; 2016 Jan; 85():56-76. PubMed ID: 26342775 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage. Castanares-Zapatero D; Hantson P Ann Intensive Care; 2011 May; 1(1):12. PubMed ID: 21906344 [TBL] [Abstract][Full Text] [Related]
34. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947 [TBL] [Abstract][Full Text] [Related]